NovAccess Global Inc. (OTCMKTS:XSNX – Get Free Report) was the recipient of a large decline in short interest in April. As of April 15th, there was short interest totalling 400 shares, a decline of 99.4% from the March 31st total of 65,900 shares. Based on an average daily trading volume, of 1,568,900 shares, the days-to-cover ratio is currently 0.0 days.
NovAccess Global Price Performance
Shares of OTCMKTS:XSNX opened at $0.01 on Friday. The company’s 50-day moving average price is $0.01 and its two-hundred day moving average price is $0.03. NovAccess Global has a one year low of $0.01 and a one year high of $0.22.
NovAccess Global (OTCMKTS:XSNX – Get Free Report) last issued its quarterly earnings results on Tuesday, February 27th. The company reported $0.01 EPS for the quarter.
About NovAccess Global
NovAccess Global Inc, a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. The company was incorporated in 1997 and is headquartered in Chagrin Falls, Ohio.
Further Reading
- Five stocks we like better than NovAccess Global
- Insider Trades May Not Tell You What You Think
- 3 Stocks Leading the U.S. Agriculture Comeback
- 3 Fintech Stocks With Good 2021 Prospects
- How to Use Put Debit Spreads to Profit From Falling Stocks
- Financial Services Stocks Investing
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for NovAccess Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovAccess Global and related companies with MarketBeat.com's FREE daily email newsletter.
